{
    "Trade/Device Name(s)": [
        "Wondfo Cannabinoids Urine Test",
        "Wondfo Propoxyphene Urine Test",
        "Cannabinoids Urine Test",
        "Propoxyphene Urine Test"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K121557",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020771",
        "K040445"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "JXN"
    ],
    "Summary Letter Date": "June 26, 2012",
    "Summary Letter Received Date": "July 16, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3870",
        "21CFR862.3700"
    ],
    "Regulation Name(s)": [
        "Cannabinoid Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "11-nor-\u03949-THC-9-COOH",
        "d-propoxyphene"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Dip Card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Cannabinoids and Propoxyphene Urine Tests, lateral flow immunochromatographic assays for drugs of abuse detection in urine.",
    "Indications for Use Summary": "Qualitative determination of 11-nor-\u03949-THC-9-COOH and d-propoxyphene in human urine at specific cut-off concentrations; Propoxyphene test for prescription use, Cannabinoids test for OTC and prescription use.",
    "fda_folder": "Toxicology"
}